Literature DB >> 33075373

STX2 drives colorectal cancer proliferation via upregulation of EXOSC4.

Yong-Xia Wang1, Yong-Zhen Li1, Wen-Li Zhao1, Zhe-Ying Zhang1, Xin-Lai Qian2, Guo-Yang He3.   

Abstract

AIMS: To explore the biological function and mechanism of Syntaxin2 (STX2) in Colorectal cancer (CRC) proliferation. MAIN
METHODS: A series of gain- and loss-of-function analysis were conducted the to explore the biological function of STX2 in CRC proliferation in vivo and in vitro. Western blot, Co-immunoprecipitation (Co-IP) and the functional analyses were taken to analyze the regulative role of STX2 on Exosome Complex 4 (EXOSC4) in CRC proliferation; Immunohistochemistry (IHC) and Real-time quantitative polymerase chain reaction (qPCR) were used to further verify the relationship between the expression of STX2 and EXOSC4 in human CRC samples. KEY
FINDINGS: Our study revealed that the over-expression of STX2 promoted CRC proliferation, while knockdown of STX2 repressed CRC proliferation; STX2 promoted CRC proliferation via increasing EXOSC4 protein; There was a positive correlation between STX2 and EXOSC4 expression. SIGNIFICANCE: The current data verify that STX2 drives the proliferation of CRC via increasing the expression of EXOSC4.
Copyright © 2020. Published by Elsevier Inc.

Entities:  

Keywords:  Colorectal cancer; EXOSC4; Proliferation; STX2

Mesh:

Substances:

Year:  2020        PMID: 33075373     DOI: 10.1016/j.lfs.2020.118597

Source DB:  PubMed          Journal:  Life Sci        ISSN: 0024-3205            Impact factor:   5.037


  4 in total

Review 1.  Emerging roles of exosome-derived biomarkers in cancer theranostics: messages from novel protein targets.

Authors:  Jiongjia Cheng; Xiaofeng Wang; Xuechun Yuan; Guangxiang Liu; Qian Chu
Journal:  Am J Cancer Res       Date:  2022-05-15       Impact factor: 5.942

2.  RNA Exosome Component EXOSC4 Amplified in Multiple Cancer Types Is Required for the Cancer Cell Survival.

Authors:  Kenzui Taniue; Tanzina Tanu; Yuki Shimoura; Shuhei Mitsutomi; Han Han; Rika Kakisaka; Yusuke Ono; Nobue Tamamura; Kenji Takahashi; Youichiro Wada; Yusuke Mizukami; Nobuyoshi Akimitsu
Journal:  Int J Mol Sci       Date:  2022-01-02       Impact factor: 5.923

3.  Downregulation of DEAD-box helicase 21 (DDX21) inhibits proliferation, cell cycle, and tumor growth in colorectal cancer via targeting cell division cycle 5-like (CDC5L).

Authors:  Kai Wang; Baosong Li; Peng Fan; Xiang Ren; Hong Jiang
Journal:  Bioengineered       Date:  2021-12       Impact factor: 3.269

4.  Exosome Component 4 Promotes Epithelial Ovarian Cancer Cell Proliferation, Migration, and Invasion via the Wnt Pathway.

Authors:  Chang Xiong; Zhongfeng Sun; Jinjin Yu; Yaying Lin
Journal:  Front Oncol       Date:  2021-12-08       Impact factor: 6.244

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.